Lyell Wealth Management LP boosted its holdings in Stryker Corporation (NYSE:SYK – Free Report) by 2.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 38,010 shares of the medical technology company’s stock after acquiring an additional 869 shares during the period. Stryker accounts for about 1.2% of Lyell Wealth Management LP’s portfolio, making the stock its 28th largest holding. Lyell Wealth Management LP’s holdings in Stryker were worth $15,038,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the business. Mar Vista Investment Partners LLC raised its position in Stryker by 10.2% in the first quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company’s stock valued at $33,572,000 after purchasing an additional 8,353 shares during the period. United Services Automobile Association purchased a new stake in Stryker in the first quarter valued at approximately $2,857,000. AXS Investments LLC raised its position in Stryker by 13.7% in the first quarter. AXS Investments LLC now owns 8,827 shares of the medical technology company’s stock valued at $3,286,000 after purchasing an additional 1,062 shares during the period. Park Edge Advisors LLC purchased a new stake in Stryker in the second quarter valued at approximately $679,000. Finally, Hendley & Co. Inc. raised its position in Stryker by 60.3% in the second quarter. Hendley & Co. Inc. now owns 14,018 shares of the medical technology company’s stock valued at $5,546,000 after purchasing an additional 5,274 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Stryker
In other news, insider Viju Menon sold 500 shares of the stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the completion of the sale, the insider owned 12,511 shares in the company, valued at approximately $4,886,921.71. This represents a 3.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the sale, the director owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.20% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on Stryker
Stryker Stock Performance
NYSE SYK opened at $374.67 on Monday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. The company has a market capitalization of $143.24 billion, a PE ratio of 49.63, a P/E/G ratio of 2.70 and a beta of 0.94. The company has a fifty day moving average of $379.40 and a two-hundred day moving average of $378.85.
Stryker (NYSE:SYK – Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.07 by $0.06. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. During the same quarter in the prior year, the firm posted $2.81 earnings per share. Stryker’s revenue for the quarter was up 11.1% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.
Stryker Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s dividend payout ratio is currently 44.50%.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
See Also
- Five stocks we like better than Stryker
- What Is WallStreetBets and What Stocks Are They Targeting?
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- Why Are These Companies Considered Blue Chips?
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- Compound Interest and Why It Matters When Investing
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.